Right heart/pulmonary circulation unit assessment during exercise, a need for a global view of the loop.
暂无分享,去创建一个
[1] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.
[2] C. Tribouilloy,et al. Dynamic drug-induced organic mitral regurgitation during exercise echocardiography following chronic exposure to ergotamine. , 2015, International journal of cardiology.
[3] R. Buys,et al. Clinical significance of dynamic pulmonary vascular resistance in two populations at risk of pulmonary arterial hypertension. , 2015, European heart journal cardiovascular Imaging.
[4] Simon Gibbs,et al. [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.
[5] Erwan Donal,et al. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. , 2014, European heart journal cardiovascular Imaging.
[6] M. Sprynger,et al. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis. , 2014, International Journal of Cardiology.
[7] N. Chesler,et al. Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. , 2012, Chest.
[8] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[9] W. Piwowarska,et al. Ergotamine-induced cardiovascular toxicity: mechanisms and clinical significance. , 2010, International journal of cardiology.
[10] J. Bruguera,et al. Spontaneous coronary artery dissection in ergotamine abuse. , 2007, International journal of cardiology.
[11] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[12] A. Shimony,et al. Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine. , 2006, International journal of cardiology.